EUVIMEDEUVIMED entdecken
Crossref

Comparison of serum midkine levels between pregnant women with and without pre‐eclampsia: A case–control study from a tertiary hospital

Bedri Sakcak iD, Ezgi Turgut iD, Ramazan Denizli iD, Nihat Farisogullari iD, Atakan Tanacan iD, Nuray Yazihan iD, Dilek Sahin iD

International Journal of Gynecology & Obstetrics · 2023

DOI: 10.1002/ijgo.14677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2023. Verfasst von Bedri Sakcak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Perinatology, Department of Obstetrics and Gynecology, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate changes in maternal serum midkine levels in pre‐eclampsia.

Methods

This study included 40 pregnant women with pre‐eclampsia and 66 healthy pregnant women in the control group. Demographic data, laboratory results, and midkine levels were compared between the groups.

Results

The pre‐eclampsia and control groups were similar in terms of demographics. The midkine level of pregnant women with pre‐eclampsia was significantly higher than that of the controls (0.54 ± 0.23 and 0.31 ± 0.19 ng/mL, respectively, P < 0.001). According to the receiver operating characteristic analysis, the optimal cut‐off value of midkine was determined as 0.37 ng/mL, at which it had 75% sensitivity and 74% specificity (area under the curve: 0.815, 95% confidence interval 0.73–0.89, P < 0.001).

Conclusion

The serum midkine level was significantly higher in pregnant women with pre‐eclampsia. Midkine seems to be associated with complicated inflammatory processes leading to pre‐eclampsia. Further study protocols can be planned to investigate the role of midkine in the prediction of pre‐eclampsia as a novel marker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPregnancyFemaleHumansCase-Control StudiesPregnant PeopleMidkineTertiary Care CentersBiomarkers

Stichwörter der Autor:innen

biomarkersinflammationmidkinepre-eclampsiarisk prediction

Substanzen

MidkineBiomarkers

Autor:innen und Institutionen

  • Division of Perinatology, Department of Obstetrics and Gynecology, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey.
  • Department of Pathophysiology, Internal Medicine, Ankara University Medical School, Ankara, Turkey.
  • Division of Perinatology, Department of Obstetrics and Gynecology, Turkish Ministry of Health Ankara City Hospital, University of Health Sciences, Ankara, Turkey.

ORCID-Profile: Bedri Sakcak, Ezgi Turgut, Ramazan Denizli, Nihat Farisogullari, Atakan Tanacan, Nuray Yazihan, Dilek Sahin

Zitieren

APA

Sakcak, B., Turgut, E., Denizli, R., Farisogullari, N., Tanacan, A., Yazihan, N., & Sahin, D. (2023). Comparison of serum midkine levels between pregnant women with and without pre‐eclampsia: A case–control study from a tertiary hospital. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.14677

Vancouver

Sakcak B, Turgut E, Denizli R, Farisogullari N, Tanacan A, Yazihan N, et al. Comparison of serum midkine levels between pregnant women with and without pre‐eclampsia: A case–control study from a tertiary hospital. International Journal of Gynecology & Obstetrics. 2023. doi:10.1002/ijgo.14677

BibTeX
@article{Sakcak2023,
  author = {Sakcak, Bedri and Turgut, Ezgi and Denizli, Ramazan and Farisogullari, Nihat and Tanacan, Atakan and Yazihan, Nuray and Sahin, Dilek},
  title = {Comparison of serum midkine levels between pregnant women with and without pre‐eclampsia: A case–control study from a tertiary hospital},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2023},
  doi = {10.1002/ijgo.14677}
}
Kostenlos starten →